A Phase II Study of Chemotherapy and Immune Checkpoint Blockade With Pembrolizumab in the Perioperative and Maintenance Treatment of Locoregional Gastric or GE Junction Adenocarcinoma.
Phase of Trial: Phase II
Latest Information Update: 21 Apr 2017
At a glance
- Drugs Capecitabine (Primary) ; Epirubicin (Primary) ; Oxaliplatin (Primary) ; Pembrolizumab (Primary)
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- 29 Jan 2017 Status changed from not yet recruiting to recruiting.
- 30 Sep 2016 New trial record